| Pharmaceutical Information |
| Drug Name |
Methohexital sodium |
| Drug ID |
BADD_D01417 |
| Description |
An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia. |
| Indications and Usage |
Methohexital is indicated for use as an intravenous anaesthetic. It has also been commonly used to induce deep sedation. |
| Marketing Status |
approved |
| ATC Code |
N01AF01; N05CA15 |
| DrugBank ID |
DB00474
|
| KEGG ID |
D00712
|
| MeSH ID |
D008723
|
| PubChem ID |
23690443
|
| TTD Drug ID |
D0S8TD
|
| NDC Product Code |
42023-105 |
| UNII |
60200PNZ7Q
|
| Synonyms |
Methohexital | Methohexitone | Brevimytal Natrium | Natrium, Brevimytal | Brietal-Sodium | Brietal Sodium | Methohexital Sodium | Sodium, Methohexital | Methohexital, Monosodium Salt | Monosodium Salt Methohexital | Brevital | Brietal |
|
| Chemical Information |
| Molecular Formula |
C14H17N2NaO3 |
| CAS Registry Number |
309-36-4 |
| SMILES |
CCC#CC(C)C1(C(=O)N=C(N(C1=O)C)[O-])CC=C.[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Cardiovascular insufficiency | 02.11.01.011; 24.06.03.005 | - | - | - |
|
|
|
